- Inhibitors
- Angiogenesis
- EGFR
- Tyrosine Kinase/Adaptors
- PI3K/Akt/mTOR Signaling
- Quinazoline and Quinoline Derivatives
Product Information
Name:Icotinib
Synonyms:
- Conmana
- BPI-2009H
- BPI-2009
Brand:Targetmol
Description:Icotinib (Conmana) is an orally available quinazoline-based inhibitor of epidermal growth factor receptor (EGFR), with potential antineoplastic activity.
Notice:Our products are intended for lab use only. For any other use, please contact us.
Chemical properties
Molecular weight:391.42
Formula:C22H21N3O4
Purity:99.76% - 99.94%
Color/Form:Solid
Technical inquiry about: Icotinib
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
